Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Pulmonary therapeutics Market Research Reports

Titlepublishedprice

Emphysema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... tive of the Emphysema Report is to understand the market and pipeline status of the drugs around the Emphysema to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strategie......"
01-Sep-2016$2000

Bacterial Pneumonia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... key objective of the Bacterial Pneumonia Report is to understand the market and pipeline status of the drugs around the Bacterial Pneumonia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage o......"
01-Sep-2016$2000

Berylliosis (Chronic Beryllium Disease)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... across the globe. A key objective of the Berylliosis (Chronic Beryllium Disease) Report is to understand the market and pipeline status of the drugs around the Berylliosis (Chronic Beryllium Disease) to explore the generic development opportunities,......"
01-Sep-2016$2000

Bronchitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... ctive of the Bronchitis Report is to understand the market and pipeline status of the drugs around the Bronchitis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strate......"
01-Sep-2016$2000

Chronic Obstructive Pulmonary Disease (COPD) - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... se for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Chronic Obstructive Pulmonary Disease (COPD) forec......"
01-Sep-2016$4950

Community Acquired Pneumonia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... globe. A key objective of the Community Acquired Pneumonia Report is to understand the market and pipeline status of the drugs around the Community Acquired Pneumonia to explore the generic development opportunities, licensing opportunities and to g......"
01-Sep-2016$2000

Idiopathic Pulmonary Fibrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... e globe. A key objective of the Idiopathic Pulmonary Fibrosis Report is to understand the market and pipeline status of the drugs around the Idiopathic Pulmonary Fibrosis to explore the generic development opportunities, licensing opportunities and t......"
01-Sep-2016$2000

Pneumocystis Infection-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... . A key objective of the Pneumocystis Infection Report is to understand the market and pipeline status of the drugs around the Pneumocystis Infection to explore the generic development opportunities, licensing opportunities and to gain competitive ad......"
01-Sep-2016$2000

Pneumonia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... tive of the Pneumonia Report is to understand the market and pipeline status of the drugs around the Pneumonia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strategie......"
01-Sep-2016$2000

Pulmonary Edema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... objective of the Pulmonary Edema Report is to understand the market and pipeline status of the drugs around the Pulmonary Edema to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing ......"
01-Sep-2016$2000